134 related articles for article (PubMed ID: 19424633)
1. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.
Androutsopoulos VP; Mahale S; Arroo RR; Potter G
Oncol Rep; 2009 Jun; 21(6):1525-8. PubMed ID: 19424633
[TBL] [Abstract][Full Text] [Related]
2. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.
Androutsopoulos VP; Ruparelia K; Arroo RR; Tsatsakis AM; Spandidos DA
Toxicology; 2009 Oct; 264(3):162-70. PubMed ID: 19666078
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.
Androutsopoulos V; Arroo RR; Hall JF; Surichan S; Potter GA
Breast Cancer Res; 2008; 10(3):R39. PubMed ID: 18454852
[TBL] [Abstract][Full Text] [Related]
4. Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450.
Androutsopoulos V; Wilsher N; Arroo RR; Potter GA
Cancer Lett; 2009 Feb; 274(1):54-60. PubMed ID: 18976853
[TBL] [Abstract][Full Text] [Related]
5. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
[TBL] [Abstract][Full Text] [Related]
6. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
Surichan S; Arroo RR; Tsatsakis AM; Androutsopoulos VP
Toxicol In Vitro; 2018 Aug; 50():274-284. PubMed ID: 29626627
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
9. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation.
Androutsopoulos VP; Spandidos DA
J Nutr Biochem; 2013 Feb; 24(2):496-504. PubMed ID: 22749133
[TBL] [Abstract][Full Text] [Related]
10. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes.
Surichan S; Arroo RR; Ruparelia K; Tsatsakis AM; Androutsopoulos VP
Food Chem Toxicol; 2018 Mar; 113():228-235. PubMed ID: 29408579
[TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
[TBL] [Abstract][Full Text] [Related]
12. Bioactivation of the citrus flavonoid nobiletin by CYP1 enzymes in MCF7 breast adenocarcinoma cells.
Surichan S; Androutsopoulos VP; Sifakis S; Koutala E; Tsatsakis A; Arroo RR; Boarder MR
Food Chem Toxicol; 2012 Sep; 50(9):3320-8. PubMed ID: 22743247
[TBL] [Abstract][Full Text] [Related]
13. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
14. Activation of aminoflavone (NSC 686288) by a sulfotransferase is required for the antiproliferative effect of the drug and for induction of histone gamma-H2AX.
Meng LH; Shankavaram U; Chen C; Agama K; Fu HQ; Gonzalez FJ; Weinstein J; Pommier Y
Cancer Res; 2006 Oct; 66(19):9656-64. PubMed ID: 17018623
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via activation of cell signaling proteins and CYP1-mediated metabolism.
Androutsopoulos VP; Tsatsakis AM
Toxicol Lett; 2014 Oct; 230(2):304-13. PubMed ID: 23994263
[TBL] [Abstract][Full Text] [Related]
16. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
[TBL] [Abstract][Full Text] [Related]
17. (
Gilbert J; De Iuliis GN; Tarleton M; McCluskey A; Sakoff JA
Mol Pharmacol; 2018 Feb; 93(2):168-177. PubMed ID: 29269419
[TBL] [Abstract][Full Text] [Related]
18. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
[TBL] [Abstract][Full Text] [Related]
19. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity.
Ciolino HP; Wang TT; Yeh GC
Cancer Res; 1998 Jul; 58(13):2754-60. PubMed ID: 9661887
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor properties of methoxylated analogues of resveratrol in malignant MCF-7 but not in non-tumorigenic MCF-10A mammary epithelial cell lines.
van den Brand AD; Villevoye J; Nijmeijer SM; van den Berg M; van Duursen MBM
Toxicology; 2019 Jun; 422():35-43. PubMed ID: 31004704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]